Kuros Biosciences AG (KURN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kuros Biosciences AG (KURN) has a cash flow conversion efficiency ratio of 0.029x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF1.94 Million ≈ $2.46 Million USD) by net assets (CHF66.93 Million ≈ $84.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Kuros Biosciences AG to measure how much of total assets are equity-financed.
Kuros Biosciences AG - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Kuros Biosciences AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Kuros Biosciences AG cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Kuros Biosciences AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kuros Biosciences AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Compass Diversified Holdings
NYSE:CODI
|
0.045x |
|
Ridley Corporation Ltd
AU:RIC
|
0.154x |
|
Beijing Asiacom Information Technology Co.Ltd
SHE:301085
|
N/A |
|
Guangdong Silvere Sci and Tech
SHE:300221
|
0.050x |
|
Henan Senyuan Electric Co Ltd
SHE:002358
|
-0.002x |
|
NEW HORIZ.HEAL. DL-00005
F:6YZ
|
N/A |
|
ASRock Inc
TW:3515
|
-0.037x |
|
Whirlpool S.A
SA:WHRL3
|
0.421x |
Annual Cash Flow Conversion Efficiency for Kuros Biosciences AG (2004–2025)
The table below shows the annual cash flow conversion efficiency of Kuros Biosciences AG from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Kuros Biosciences AG market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF66.93 Million ≈ $84.62 Million |
CHF-377.87K ≈ $-477.73K |
-0.006x | -110.56% |
| 2024-12-31 | CHF58.75 Million ≈ $74.27 Million |
CHF3.14 Million ≈ $3.97 Million |
0.053x | +134.27% |
| 2023-12-31 | CHF56.71 Million ≈ $71.70 Million |
CHF-8.84 Million ≈ $-11.18 Million |
-0.156x | -46.14% |
| 2022-12-31 | CHF68.86 Million ≈ $87.06 Million |
CHF-7.35 Million ≈ $-9.29 Million |
-0.107x | -50.63% |
| 2021-12-31 | CHF76.98 Million ≈ $97.32 Million |
CHF-5.45 Million ≈ $-6.89 Million |
-0.071x | +35.13% |
| 2020-12-31 | CHF84.60 Million ≈ $106.96 Million |
CHF-9.24 Million ≈ $-11.68 Million |
-0.109x | +21.63% |
| 2019-12-31 | CHF77.86 Million ≈ $98.43 Million |
CHF-10.85 Million ≈ $-13.72 Million |
-0.139x | +16.98% |
| 2018-12-31 | CHF76.48 Million ≈ $96.70 Million |
CHF-12.84 Million ≈ $-16.23 Million |
-0.168x | -14.97% |
| 2017-12-31 | CHF73.14 Million ≈ $92.47 Million |
CHF-10.68 Million ≈ $-13.50 Million |
-0.146x | +37.09% |
| 2016-12-31 | CHF38.32 Million ≈ $48.45 Million |
CHF-8.89 Million ≈ $-11.24 Million |
-0.232x | +93.82% |
| 2015-12-31 | CHF669.00K ≈ $845.80K |
CHF-2.51 Million ≈ $-3.18 Million |
-3.758x | -514.73% |
| 2014-12-31 | CHF-26.22 Million ≈ $-33.15 Million |
CHF-23.76 Million ≈ $-30.04 Million |
0.906x | +119.99% |
| 2013-12-31 | CHF4.23 Million ≈ $5.35 Million |
CHF-19.17 Million ≈ $-24.24 Million |
-4.532x | -293.95% |
| 2012-12-31 | CHF10.03 Million ≈ $12.68 Million |
CHF-11.54 Million ≈ $-14.59 Million |
-1.150x | -252.56% |
| 2011-12-31 | CHF-11.68 Million ≈ $-14.77 Million |
CHF-8.81 Million ≈ $-11.13 Million |
0.754x | +206.14% |
| 2010-12-31 | CHF6.59 Million ≈ $8.34 Million |
CHF-4.68 Million ≈ $-5.92 Million |
-0.710x | +61.61% |
| 2009-12-31 | CHF8.24 Million ≈ $10.42 Million |
CHF-15.25 Million ≈ $-19.28 Million |
-1.850x | -111.33% |
| 2008-12-31 | CHF31.86 Million ≈ $40.28 Million |
CHF-27.89 Million ≈ $-35.27 Million |
-0.876x | -983.67% |
| 2007-12-31 | CHF54.43 Million ≈ $68.82 Million |
CHF-4.40 Million ≈ $-5.56 Million |
-0.081x | +87.07% |
| 2006-12-31 | CHF45.90 Million ≈ $58.03 Million |
CHF-28.67 Million ≈ $-36.25 Million |
-0.625x | -70.75% |
| 2005-12-31 | CHF74.01 Million ≈ $93.57 Million |
CHF-27.08 Million ≈ $-34.23 Million |
-0.366x | -29.32% |
| 2004-12-31 | CHF80.17 Million ≈ $101.36 Million |
CHF-22.68 Million ≈ $-28.68 Million |
-0.283x | -- |
About Kuros Biosciences AG
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; Ma… Read more